Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849
摘要:
A strategy of systematically targeting more rigid analogues of the known MCH R1 receptor antagonist, SB-568849, serendipitously uncovered a binding mode accessible to N-aryl-phthalimide ligands. Optimisation to improve the stability of this compound class led to the discovery of novel N-aryl-quinazolinones, benzotriazinones and thienopyrimidinones as selective ligands with good,affinity for human melanin-concentrating hormone receptor 1. (c) 2006 Elsevier Ltd. All rights reserved.
Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849
摘要:
A strategy of systematically targeting more rigid analogues of the known MCH R1 receptor antagonist, SB-568849, serendipitously uncovered a binding mode accessible to N-aryl-phthalimide ligands. Optimisation to improve the stability of this compound class led to the discovery of novel N-aryl-quinazolinones, benzotriazinones and thienopyrimidinones as selective ligands with good,affinity for human melanin-concentrating hormone receptor 1. (c) 2006 Elsevier Ltd. All rights reserved.
[EN] PYRIMIDINONES AS MELANIN CONCENTRATING HORMONE RECEPTOR 1<br/>[FR] PYRIMIDINONES EN TANT QUE RECEPTEUR 1 DE L'HORMONE DE CONCENTRATION DE LA MELANINE
申请人:SMITHKLINE BEECHAM PLC
公开号:WO2003033476A1
公开(公告)日:2003-04-24
A compound of formula (Ia) comprising a pharmaceutically acceptable salt or solvate thereof, formulations, processes of preparing, and methods of administering to mammals are provided
本发明提供了化合物(Ia)的配方,包括其药物可接受的盐或溶剂,制备过程和哺乳动物的给药方法。
Pyrimidinones as melanin concentrating hormone receptor 1
申请人:——
公开号:US20040220404A1
公开(公告)日:2004-11-04
A compound of formula (Ia) comprising a pharmaceutically acceptable salt or solvate thereof, formulations, processes of preparing, and methods of administering to mammals are provided
1
提供了一种化合物(Ia)的配方,包括其药用可接受的盐或溶剂,制备过程以及对哺乳动物的给药方法。
PYRIMIDINONES AS MELANIN CONCENTRATING HORMONE RECEPTOR 1
申请人:SMITHKLINE BEECHAM PLC
公开号:EP1442025B1
公开(公告)日:2007-03-07
US7285557B2
申请人:——
公开号:US7285557B2
公开(公告)日:2007-10-23
Discovery of potent and stable conformationally constrained analogues of the MCH R1 antagonist SB-568849
作者:David R. Witty、John Bateson、Guillaume J. Hervieu、Kamal Al-Barazanji、Phillip Jeffrey、Dieter Hamprecht、Andrea Haynes、Christopher N. Johnson、Alison I. Muir、Peter J. O’Hanlon、Geoffrey Stemp、Alex J. Stevens、Kevin Thewlis、Kim Y. Winborn
DOI:10.1016/j.bmcl.2006.06.061
日期:2006.9
A strategy of systematically targeting more rigid analogues of the known MCH R1 receptor antagonist, SB-568849, serendipitously uncovered a binding mode accessible to N-aryl-phthalimide ligands. Optimisation to improve the stability of this compound class led to the discovery of novel N-aryl-quinazolinones, benzotriazinones and thienopyrimidinones as selective ligands with good,affinity for human melanin-concentrating hormone receptor 1. (c) 2006 Elsevier Ltd. All rights reserved.